Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...
These actions could postpone NIH-funded clinical trials and create cash flow issues for domestic biotech companies.
Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...
There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...
The government of Japan has approved a draft revision of a law aimed at strengthening the development of new drugs in the ...
The company states the acquisition will further MERIT’s service offerings, allowing for a seamless transition from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results